Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors

Mol Cell Proteomics. 2020 Jul;19(7):1236-1247. doi: 10.1074/mcp.RA119.001846. Epub 2020 May 1.

Abstract

The presentation of post-translationally modified (PTM) peptides by cell surface HLA molecules has the potential to increase the diversity of targets for surveilling T cells. Although immunopeptidomics studies routinely identify thousands of HLA-bound peptides from cell lines and tissue samples, in-depth analyses of the proportion and nature of peptides bearing one or more PTMs remains challenging. Here we have analyzed HLA-bound peptides from a variety of allotypes and assessed the distribution of mass spectrometry-detected PTMs, finding deamidation of asparagine or glutamine to be highly prevalent. Given that asparagine deamidation may arise either spontaneously or through enzymatic reaction, we assessed allele-specific and global motifs flanking the modified residues. Notably, we found that the N-linked glycosylation motif NX(S/T) was highly abundant across asparagine-deamidated HLA-bound peptides. This finding, demonstrated previously for a handful of deamidated T cell epitopes, implicates a more global role for the retrograde transport of nascently N-glycosylated polypeptides from the ER and their subsequent degradation within the cytosol to form HLA-ligand precursors. Chemical inhibition of Peptide:N-Glycanase (PNGase), the endoglycosidase responsible for the removal of glycans from misfolded and retrotranslocated glycoproteins, greatly reduced presentation of this subset of deamidated HLA-bound peptides. Importantly, there was no impact of PNGase inhibition on peptides not containing a consensus NX(S/T) motif. This indicates that a large proportion of HLA-I bound asparagine deamidated peptides are generated from formerly glycosylated proteins that have undergone deglycosylation via the ER-associated protein degradation (ERAD) pathway. The information herein will help train deamidation prediction models for HLA-peptide repertoires and aid in the design of novel T cell therapeutic targets derived from glycoprotein antigens.

Keywords: HLA; Immunology; N-glycosylation; de-glycosylation; deamidation; immunopeptidomics; peptides; peptidomics; post-translational modifications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Amino Acid Motifs
  • Asparagine / metabolism*
  • Cell Line
  • Chromatography, Liquid
  • Deamination
  • Endoplasmic Reticulum-Associated Degradation
  • Epitopes, T-Lymphocyte / metabolism
  • Glycoproteins / metabolism*
  • Glycosylation
  • Histocompatibility Antigens Class I / metabolism*
  • Histocompatibility Antigens Class II / metabolism*
  • Humans
  • Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase / antagonists & inhibitors
  • Peptides / metabolism*
  • Protein Processing, Post-Translational
  • Proteomics
  • Tandem Mass Spectrometry

Substances

  • Amino Acid Chloromethyl Ketones
  • Epitopes, T-Lymphocyte
  • Glycoproteins
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
  • Peptides
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • Asparagine
  • Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase